November 6, 2023 —  Bristol Myers Squibb announced that research across the company’s cardiovascular franchise will be ...
November 6, 2023 — Atrial fibrillation (AF) diagnosis was associated with a 45% increased risk of mild cognitive ...
November 3, 2023 — The American Heart Association will present its 2023 Research Achievement Award to Marlene ...
November 3, 2023 — The national Board of Directors of the American Heart Association last week voted to provide full ...
November 2, 2023 — The latest STRIKE-PE data, presented by Penumbra, Inc. at the Vascular Interventional Advances ...
November 2, 2023 — Contego Medical Inc. announced the presentation of late-breaking clinical results from the ...
November 2, 2023 — The second round of late-breaking clinical trials results from the Vascular InterVentional Advances ...
November 1, 2023 — The VIVA Foundation has announced the results for the first Late-Breaking Clinical Trial sessions at ...
October 31, 2023 — Results of four late-breaking clinical trials presented during the The VEINS Conference 2023, taking ...
October 31, 2023 — Edwards Lifesciences Corporation announced one-year results from CLASP IID, the first randomized ...
October 31, 2023 — SMT (Sahajanand Medical Technologies), a leading medical device company in India, focused on ...
October 31, 2023 — Tenaya Therapeutics, Inc., a clinical-stage biotechnology company with a mission to discover, develop ...
October 30, 2023 — Shockwave Medical, Inc., which develops technologies for the treatment of cardiovascular disease, has ...
October 30, 2023 — Boston Scientific Corporation on Friday announced positive 12-month results from the pivotal AGENT ...
October 30, 2023 — Abbott announced late-breaking data from the LIFE-BTK clinical trial evaluating the Esprit BTK ...